What is the address of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE?

The registered office of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE is located at Oudebaan 190a, 1790 Affligem.

Is DOKTER EVELYN DESPIERRE - GYNAECOLOGIE still active?

Yes. According to the CBE (1 October 2026) DOKTER EVELYN DESPIERRE - GYNAECOLOGIE is active, legal situation “Normale toestand”, started on 12 December 2017.

Is DOKTER EVELYN DESPIERRE - GYNAECOLOGIE registered on Peppol?

Yes, DOKTER EVELYN DESPIERRE - GYNAECOLOGIE is registered on the Peppol network with ID 0208:0685862650.

What is the enterprise number of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE?

The enterprise number of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE is BE0685862650.

When was DOKTER EVELYN DESPIERRE - GYNAECOLOGIE founded?

DOKTER EVELYN DESPIERRE - GYNAECOLOGIE was founded on 12 December 2017.

Who are the directors of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE?

According to the 2025 annual accounts, the directors of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE are: Peter Durie, Evelyn Despierre.

Is DOKTER EVELYN DESPIERRE - GYNAECOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 December 2017; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DOKTER EVELYN DESPIERRE - GYNAECOLOGIE make in 2025?

DOKTER EVELYN DESPIERRE - GYNAECOLOGIE posted a profit after taxes of € 90,456 in financial year 2025.

What is the revenue of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE?

As a small company, DOKTER EVELYN DESPIERRE - GYNAECOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 207,211.

DOKTER EVELYN DESPIERRE - GYNAECOLOGIE (Private Limited)

Dossier DOKTER EVELYN DESPIERRE - GYNAECOLOGIE, printed on 1 October 2026 from databakkes.be/en/0685862650/dokter-evelyn-despierre-gynaecologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER EVELYN DESPIERRE - GYNAECOLOGIE from Affligem, company number BE0685862650, closed financial year 2025 with a result of € 90,456 after tax. For that financial year DOKTER EVELYN DESPIERRE - GYNAECOLOGIE recorded a gross margin of € 207,211 and equity of € 282,137. Compared with financial year 2024, the result moved from € 164,921 to € 90,456. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Healthy

€ 282,137

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 90,456

▼ 45% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 146,668

▼ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 16,855

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 240,566

▼ 21% vs 2024

€ 64,604 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 3,182

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 238,603 Gross margin 2022: € 238,603 First fiscal year in the series	€ 281,362 Gross margin 2023: € 281,362 ▲ 18% vs 2022 (€ 238,603) Favourable step	€ 294,751 Gross margin 2024: € 294,751 ▲ 5% vs 2023 (€ 281,362) Favourable step	€ 207,211 Gross margin 2025: € 207,211 ▼ 30% vs 2024 (€ 294,751) Unfavourable step	▼ 30%
Profit after taxes	€ 142,922 Profit after taxes 2022: € 142,922 First fiscal year in the series	€ 160,781 Profit after taxes 2023: € 160,781 ▲ 12% vs 2022 (€ 142,922) Favourable step	€ 164,921 Profit after taxes 2024: € 164,921 ▲ 3% vs 2023 (€ 160,781) Favourable step	€ 90,456 Profit after taxes 2025: € 90,456 ▼ 45% vs 2024 (€ 164,921) Unfavourable step	▼ 45%
Equity	€ 418,979 Equity 2022: € 418,979 First fiscal year in the series	€ 349,760 Equity 2023: € 349,760 ▼ 17% vs 2022 (€ 418,979) Unfavourable step	€ 291,681 Equity 2024: € 291,681 ▼ 17% vs 2023 (€ 349,760) Unfavourable step	€ 282,137 Equity 2025: € 282,137 ▼ 3% vs 2024 (€ 291,681) Unfavourable step	▼ 3%
Total debts	€ 529,682 Total debts 2022: € 529,682 First fiscal year in the series	€ 630,834 Total debts 2023: € 630,834 ▲ 19% vs 2022 (€ 529,682) Unfavourable step	€ 697,098 Total debts 2024: € 697,098 ▲ 11% vs 2023 (€ 630,834) Unfavourable step	€ 486,227 Total debts 2025: € 486,227 ▼ 30% vs 2024 (€ 697,098) Favourable step	▼ 30%
Cash	€ 149,014 Cash 2022: € 149,014 First fiscal year in the series	€ 230,451 Cash 2023: € 230,451 ▲ 55% vs 2022 (€ 149,014) Favourable step	€ 279,819 Cash 2024: € 279,819 ▲ 21% vs 2023 (€ 230,451) Favourable step	€ 146,668 Cash 2025: € 146,668 ▼ 48% vs 2024 (€ 279,819) Unfavourable step	▼ 48%
Land & buildings	€ 351,796 Land & buildings 2022: € 351,796 First fiscal year in the series	€ 344,992 Land & buildings 2023: € 344,992 ▼ 2% vs 2022 (€ 351,796) Unchanged	€ 334,676 Land & buildings 2024: € 334,676 ▼ 3% vs 2023 (€ 344,992) Unchanged	€ 324,360 Land & buildings 2025: € 324,360 ▼ 3% vs 2024 (€ 334,676) Unchanged	▼ 3%
Retained profit	€ 400,379 Retained profit 2022: € 400,379 First fiscal year in the series	€ 331,160 Retained profit 2023: € 331,160 ▼ 17% vs 2022 (€ 400,379) Unfavourable step	€ 273,081 Retained profit 2024: € 273,081 ▼ 18% vs 2023 (€ 331,160) Unfavourable step	€ 263,537 Retained profit 2025: € 263,537 ▼ 3% vs 2024 (€ 273,081) Unfavourable step	▼ 3%
Dividend	€ 117,647 Dividend 2022: € 117,647 First fiscal year in the series	€ 230,000 Dividend 2023: € 230,000 ▲ 95% vs 2022 (€ 117,647) Unchanged	€ 223,000 Dividend 2024: € 223,000 ▼ 3% vs 2023 (€ 230,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▼ 55% vs 2024 (€ 223,000) Unchanged	▼ 55%
Bank debt	€ 430,678 Bank debt 2022: € 430,678 First fiscal year in the series	€ 367,918 Bank debt 2023: € 367,918 ▼ 15% vs 2022 (€ 430,678) Favourable step	€ 304,550 Bank debt 2024: € 304,550 ▼ 17% vs 2023 (€ 367,918) Favourable step	€ 240,566 Bank debt 2025: € 240,566 ▼ 21% vs 2024 (€ 304,550) Favourable step	▼ 21%
Balance sheet total	€ 948,661 Balance sheet total 2022: € 948,661 First fiscal year in the series	€ 980,594 Balance sheet total 2023: € 980,594 ▲ 3% vs 2022 (€ 948,661) Unchanged	€ 988,779 Balance sheet total 2024: € 988,779 ▲ 1% vs 2023 (€ 980,594) Unchanged	€ 768,364 Balance sheet total 2025: € 768,364 ▼ 22% vs 2024 (€ 988,779) Unchanged	▼ 22%

Key figures of DOKTER EVELYN DESPIERRE - GYNAECOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER EVELYN DESPIERRE - GYNAECOLOGIE?

What happened at DOKTER EVELYN DESPIERRE - GYNAECOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 90,456 (▼ 45% vs 2024). Source: NBB ↗
2023 Peter Durie became a director. NBB
2023 Evelyn Despierre became a director. NBB
Dec 12, 2017 New establishment in Affligem. KBO
Dec 12, 2017 Start of the company according to the CBE. KBO

In short

From € 142,922 profit in 2022 to € 90,456 profit in 2025.

Paid € 159,270 in corporate taxes since 2022.

Best year ever: 2024, with € 164,921 profit.

Paid out € 670,647 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER EVELYN DESPIERRE - GYNAECOLOGIE? We notify you, reason included.

Follow DOKTER EVELYN DESPIERRE - GYNAECOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Peter Durie Evelyn Despierre

DOKTER EVELYN DESPIERRE - GYNAECOLOGIE

Behind DOKTER EVELYN DESPIERRE - GYNAECOLOGIE are Peter Durie and Evelyn Despierre.

See the full network in the app

Directors

According to the 2025 annual accounts

Peter Durie

Director

since 2023

Evelyn Despierre

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Oudebaan 190a

1790 Affligem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0685.862.650
VAT number: BE 0685.862.650
Registered office: Oudebaan 190a, 1790 Affligem
Names & denominations: DOKTER EVELYN DESPIERRE - GYNAECOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 December 2017
Peppol: Active · Active since 11 Nov 2024

View on CBE Public ↗ Annual accounts (NBB) ↗